Log in
Enquire now
Parallel Bio

Parallel Bio

Parallel Bio develops immune system organoids to accelerate drug discovery using AI, robotics, and biotechnology.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
Robert DiFazio
Robert DiFazio
CTO
‌
Ari Gesher
Email Address
press@parallel.bio
Founder
Juliana Hilliard
Juliana Hilliard
Robert DiFazio
Robert DiFazio
Industry
Drug development
Drug development
Drug discovery
Drug discovery
Immunotherapy
Immunotherapy
Artificial Intelligence (AI)
Artificial Intelligence (AI)
‌
Organoid Technology
‌
Human Immune Modeling
Biotechnology
Biotechnology
Bio-inspired robotics
Bio-inspired robotics
Investors
Amplo
Amplo
‌
Undeterred Capital
AIX Ventures
AIX Ventures
‌
Jeff dean
Atypical Ventures
Atypical Ventures
Metaplanet Holdings
Metaplanet Holdings
‌
Marc Benioff
‌
Humba Ventures
Latest Funding Round Date
June 12, 2025
Latest Funding Round Amount (USD)
21,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/parallelbio
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
21,000,000
Official Website
parallel.bio

Find more companies like Parallel Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.